MICHAEL JAY ROSS Insider Trading $ASNS X4 Pharmaceuticals, Inc
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MICHAEL JAY ROSS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MICHAEL JAY ROSS. MICHAEL JAY ROSS is Director in SUTRO BIOPHARMA INC ($STRO) and Director in Ophthotech Corp. ($OPHT) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in Arsanis, Inc. ($ASNS) and Director in Deciphera Pharmaceuticals, Inc. ($DCPH).
MICHAEL JAY ROSS in X4 Pharmaceuticals, Inc
Trading Symbol: ASNSIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of MICHAEL JAY ROSS: Director
Holdings: 19,128 shares
Latest Transaction: Jun 07 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MICHAEL JAY ROSS in X4 Pharmaceuticals, Inc
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, CATB, DCPH, OPHT, STRO, ASNS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 07 2018 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | A | 16.99 | 10,000 | 169,900 | 10,000 | |
Dec 01 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | A | 10.00 | 7,324 | 73,240 | 7,324 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 50,477 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 1,474,348 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 14,635 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 692,552 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 4,747 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 224,665 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 15,246 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 721,402 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 14,587 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 690,259 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 1,380 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Option Exercise | C | 0.00 | 65,287 | 0 | 0 | |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | P | 10.00 | 16,552 | 165,520 | 1,868,961 | 1.9 M to 1.9 M (+0.89 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | P | 10.00 | 483,448 | 4,834,480 | 1,852,409 | 1.4 M to 1.9 M (+35.31 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 14,789 | 0 | 1,368,961 | 1.4 M to 1.4 M (+1.09 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 431,980 | 0 | 1,354,172 | 922.2 K to 1.4 M (+46.84 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 4,288 | 0 | 922,192 | 917.9 K to 922.2 K (+0.47 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 202,915 | 0 | 917,904 | 715 K to 917.9 K (+28.38 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 2,365 | 0 | 714,989 | 712.6 K to 715 K (+0.33 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 111,955 | 0 | 712,624 | 600.7 K to 712.6 K (+18.64 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 6,806 | 0 | 600,669 | 593.9 K to 600.7 K (+1.15 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 322,102 | 0 | 593,863 | 271.8 K to 593.9 K (+118.52 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 5,219 | 0 | 271,761 | 266.5 K to 271.8 K (+1.96 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 247,010 | 0 | 266,542 | 19.5 K to 266.5 K (+1,264.64 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 404 | 0 | 19,532 | 19.1 K to 19.5 K (+2.11 %) |
Nov 20 2017 | ASNS | Arsanis, Inc. | Ross Michael Jay | Director | Buy | C | 0.00 | 19,128 | 0 | 19,128 | 0 to 19.1 K |
Page: 1